Cardiff Oncology participates in UBS Global Biopharma Conference

CRDF•2026-11-03

Cardiff Oncology will participate in the UBS Global Biopharma Conference on November 16-17, 2026, with CEO Mani Mohindru scheduled to present a fireside chat on November 16 at 2:40 p.m. GMT.

1. Conference participation

Cardiff Oncology will participate in the UBS Global Biopharma Conference on November 16-17, 2026. President and CEO Mani Mohindru will present a fireside chat on November 16 at 2:40 p.m. GMT, and management will hold one-on-one investor meetings.

Cardiff Oncology participates in UBS Global Biopharma Conference

1. Conference participation

Related News

ZoomInfo partners with Notion to bring sales intelligence into Notion AI

International Seaways to issue about 1,100,000 unregistered shares in Bruton acquisition

Hoth ends HT-001 Phase 2a trial early on positive interim results

Copper falls to 2-1/2-month low as risk aversion grips metals

Lucid Diagnostics study shows 95% cell collection success with EsoCheck in 11,991 patients